Novo Nordisk will launch the pill form of its obesity med Wegovy in the US on Monday, saying that it could cost insured patients as little as $25 per month. Prescriptions for the starter dose …
Read More from Endpoints News
Novo Nordisk will launch the pill form of its obesity med Wegovy in the US on Monday, saying that it could cost insured patients as little as $25 per month. Prescriptions for the starter dose …
Read More from Endpoints News